(Bloomberg) -- SGS SA is in advanced talks to combine with Bureau Veritas SA, people with knowledge of the matter said, in a deal that would create a European testing and certification company with a combined market value of almost $35 billion. Most Read from Bloomberg These Homes Withstood the LA Fires. Architects Explain Why As E-Bikes Boom in NYC, Some Call for More Regulations A Blueprint for Better Bike Lanes Geneva-based SGS and France’s Bureau Veritas are working on the final details of a transaction that could be announced in the coming weeks, the people said, asking not to be identified discussing confidential information. Shares of SGS have risen more than a quarter over the last 12 months, giving the company a market value of 17.6 billion Swiss francs ($19.3 billion). Bureau Veritas is up by a similar amount over the period for a market cap of €13.5 billion ($13.9 billion). Any deal would need the support of investment firm Wendel SE, which is Bureau Veritas’s largest shareholder with a 26.5% stake, Bloomberg-compiled data show. It would also likely need to be vetted by the French government. The Lac1 fund, managed by state-owned Bpifrance SACA, last year bought a 4% holding in Bureau Veritas. While talks are at an advanced stage, they could still be delayed or falter, the people said. A representative for Neuilly-sur-Seine-based Bureau Veritas didn’t immediately provide a comment. A spokesperson for SGS couldn’t immediately be reached for comment outside regular business hours in Europe. Established in 1828, Bureau Veritas specializes in laboratory testing, inspection and certification services. It has a presence in 140 countries and about 83,000 employees globally, according to its website. In December, the company replaced Vivendi SE in France’s blue-chip CAC 40 index after the media conglomerate split into four separate entities. Bloomberg Intelligence analysts Stuart Gordon and Evgeniy Batchvarov wrote in a note in November that SGS’s new chief executive officer, Géraldine Picaud, appeared to be more aggressive on mergers and acquisitions, as the company seeks to reverse broad share-price underperformance versus its testing, inspection and certification peers over the past decade. “I need to participate actively in consolidation,” Picaud said in an interview in November. She said at the time that not a single player in the testing, inspection and certification industry accounts for more than 5% of the total market. --With assistance from Jan-Henrik Förster. (Updates with Picaud’s earlier comment in final paragraph.) Story Continues Most Read from Bloomberg Businessweek At Charles Schwab, a Fresh Start After a Close Call The Era of Finance CEOs Running Retailers Is Over Why AI Investors Should Worry About the Self-Driving Car Crash How Long Can Toyota Put Off Figuring Out EVs? Cannabis Cocktails Are Growing Quickly, But the Law Might Stop That Soon ©2025 Bloomberg L.P. View Comments
SGS Is In Talks to Combine With French Testing Firm Bureau Veritas
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...